Medium-Chain Triglyceride Oil for the Treatment of Canine Epilepsy
Publication: Berk, B. A., Law, T. H., Packer, R. M. A., Wessmann, A., Bathen‐Nöthen, A., Jokinen, T. S., Knebel, A., Tipold, A., Pelligand, L., Meads, Z., & Volk, H. A. (2020). A multicenter randomized controlled trial of effect of medium-chain triglyceride dietary supplementation on epilepsy in dogs. Journal of Veterinary Internal Medicine, 1–2.
What can we learn?
MCT oil is one component of the ketogenic diet, which has been shown to improve seizure control in people. Researchers at the Royal Veterinary College, University of London conducted a six month, multicenter, prospective, randomized, double‐blinded, placebo‐controlled crossover trial, comparing the use of a medium-chain triglyceride (MCT oil) supplement with a control supplement in the treatment of canine idiopathic epilepsy.
Conclusion - The MCT oil was well-tolerated and there was a statistically significant improvement in seizure control while dogs were taking the supplement. This was noted as a reduction in the total number of seizures reported each month and a reduction in the number of days each month in which a seizure occurred. MCT oil supplementation is a valid tool for use in the treatment of canine idiopathic epilepsy.
Read the full article here.
- The Gut Microbiome and Canine Epilepsy (07/21/2020)
- Epilepsy and the Gut Microbiome (07/21/2020)
- A Clinical Trial of Medium-Chain Triglyceride Oil for the Treatment of Canine Epilepsy (05/06/2020)
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.